Search for Clinical Trial Results

Sponsored By

Chordoma - 20 Studies Found

Status Study
Active, not recruiting Study Name: Nilotinib With Radiation for High Risk Chordoma
Condition: Chordoma
Date: 2011-07-28
Interventions:
  • Drug: Nilotinib Orally, daily

Active, not recruiting Study Name: Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
Condition: Chordoma
Date: 2010-07-28
Interventions: Drug: Imatinib + LBH589 Escalating doses of imatinib and LBH589 will be administered.
Completed Study Name: Efficacy and Safety of Imatinib in Chordoma
Condition: Chordoma
Date: 2005-09-07
Interventions: Drug: imatinib
Active, not recruiting Study Name: Proton Beam Therapy for Chordoma Patients
Condition: Chordoma
Date: 2007-07-02
Interventions:
  • Radiation: Proton Beam Therapy

Completed Study Name: Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
Condition: Chordoma
Date: 2006-06-19
Completed Study Name: Chordoma Family Study
Condition: Chordoma
Date: 2006-12-12
Recruiting Study Name: Ion Irradiation of Sacrococcygeal Chordoma
Condition: Sacral Chordoma
Date: 2013-03-09
Interventions:
  • Radiation: protons Treatment i
Not yet recruiting Study Name: CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma
Condition: Chordoma
Date: 2017-03-31
Interventions: Drug: Palbociclib application on 21 consecutive days of a 28 days cycle
Recruiting Study Name: Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
Condition: Chordoma
Date: 2016-12-02
Interventions:
  • Other: Randomized Cohort Surgi
Not yet recruiting Study Name: Afatinib in Locally Advanced and Metastatic Chordoma
Condition: Chordoma
Date: 2017-02-10
Interventions: Drug: Afatinib Afatinib will be given daily in a dose of 40 mg orally in a 4 week cycle until disease pr
Next >>>